Pathologic Considerations and Standardization in Mesothelioma Clinical Trials

被引:9
作者
Tsao, Ming-Sound [1 ,2 ]
Carbone, Michele [3 ]
Galateau-Salle, Francoise [4 ]
Moreira, Andre L. [5 ]
Nicholson, Andrew G. [6 ,7 ]
Roden, Anja C. [8 ]
Adjei, Alex A. [9 ]
Aubry, Marie-Christine [8 ]
Fennell, Dean A. [10 ]
Gomez, Daniel [11 ]
Harpole, David [12 ]
Hesdorffer, Mary [13 ]
Hirsch, Fred R. [14 ]
Liu, Geoffrey [15 ]
Malik, Shakun [16 ]
Nowak, Anna [17 ]
Peikert, Tobias [18 ]
Salgia, Ravi [19 ]
Szlosarek, Peter [20 ]
Taioli, Emanuela [21 ,22 ]
Yang, Haining [3 ]
Tsao, Anne [23 ]
Mansfield, Aaron S. [9 ]
机构
[1] Princess Margaret Canc Ctr, Dept Pathol, Toronto, ON, Canada
[2] Univ Toronto, Toronto, ON, Canada
[3] Univ Hawaii, Canc Ctr, Thorac Oncol Program, Honolulu, HI 96822 USA
[4] Ctr Leon Berard, Dept BioPathol, MESOBANK, MESOPATH,MESONAT, Lyon, France
[5] New York Univ Langone Hlth, Dept Pathol, New York, NY USA
[6] Imperial Coll, Royal Brompton & Harefield NHS Fdn Trust, Dept Histopathol, London, England
[7] Imperial Coll, Natl Heart & Lung Inst, London, England
[8] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA
[9] Mayo Clin, Div Med Oncol, 200 First St SW, Rochester, MN 55905 USA
[10] Leicester Canc Res Ctr, Mesothelioma Res Programme, Leicester, Leics, England
[11] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
[12] Duke Univ, Dept Surg, Div Cardiothorac Surg, Durham, NC USA
[13] Mesothelioma Appl Res Fdn, Alexandria, VA USA
[14] Tisch Canc Ctr, Ctr Thorac Oncol, Mt Sinai Hlth Syst, New York, NY USA
[15] Princess Margaret Canc Ctr, Toronto, ON, Canada
[16] NCI, Clin Invest Branch, Canc Therapy Evaluat Program, NIH, Bethesda, MD 20892 USA
[17] Univ Western Australia, Natl Ctr Asbestos Related Dis, Nedlands, WA, Australia
[18] Mayo Clin, Div Pulm & Crit Care Med, Rochester, MN USA
[19] City Hope Natl Med Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA USA
[20] Queen Mary Univ London, Barts Canc Inst, London, England
[21] Icahn Sch Med Mt Sinai, Dept Epidemiol, New York, NY 10029 USA
[22] Icahn Sch Med Mt Sinai, Dept Thorac Surg, New York, NY 10029 USA
[23] Univ Texas MD Anderson Canc Ctr, Dept Thoracic Head & Neck Med Oncol, Houston, TX 77030 USA
关键词
Mesothelioma; Clinical trials; Pathology; Correlatives; Pathologic classification; MALIGNANT PLEURAL MESOTHELIOMA; HEALTH-ORGANIZATION CLASSIFICATION; LIGAND; EXPRESSION; REPORTING RECOMMENDATIONS; BRCA1-ASSOCIATED PROTEIN-1; QUALITY-ASSURANCE; NEEDLE-BIOPSY; OPEN-LABEL; T-CELLS; LUNG;
D O I
10.1016/j.jtho.2019.06.020
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The accurate diagnosis of mesothelioma is critical for the appropriate clinical management of this cancer. Many issues complicate making the diagnosis of mesothelioma including the presence of reactive mesothelial cells in benign pleural effusions, the heterogeneity of mesothelioma histopathology, the relatively high incidence of other epithelial malignancies that metastasize to the pleura, and primary sarcomas that arise within the pleura. Given the rapidly evolving field of molecular profiling and the need for translational correlates in mesothelioma clinical trials, the National Cancer Institute (NCI)-International Association for the Study of Lung Cancer-Mesothelioma Applied Research Foundation Clinical Trials Planning Meeting was convened in March 2017 to develop a consensus on standard pathology guidelines for future NCI-sponsored clinical trials in mesothelioma. This consensus statement covers recommendations for specimen handling, pathologic classification and diagnosis, biobanking, and tissue correlative studies. (C) 2019 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:1704 / 1717
页数:14
相关论文
共 50 条
[41]   Review Article: Ethical Considerations in Conducting Clinical Trials [J].
Mousavinejad, Shahriar ;
Bazmi, Shabnam ;
Rezaei-Tavirani, Mostafa ;
Shamsi-Gooshki, Ehsan ;
Enjoo, Seyed Ali ;
Kiani, Mehrzad .
INTERNATIONAL JOURNAL OF MEDICAL TOXICOLOGY AND FORENSIC MEDICINE, 2021, 11 (04) :34863
[42]   Design and Analysis Considerations in Clinical Trials With a Sensitive Subpopulation [J].
Zhao, Yan D. ;
Dmitrienko, Alex ;
Tamura, Roy .
STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2010, 2 (01) :72-83
[43]   Immune checkpoint therapy of mesothelioma: Pre-clinical bases and clinical evidences [J].
Calabro, Luana ;
Ceresoli, Giovanni Luca ;
D'Incecco, Armida ;
Scherpereel, Arnaud ;
Aerts, Joachim ;
Maio, Michele .
CYTOKINE & GROWTH FACTOR REVIEWS, 2017, 36 :25-31
[44]   Comprehensive Molecular and Pathologic Evaluation of Transitional Mesothelioma Assisted by Deep Learning Approach: A Multi-Institutional Study of the International Mesothelioma Panel from the MESOPATH Reference Center [J].
Salle, Francoise Galateau ;
Le Stang, Nolwenn ;
Tirode, Franck ;
Courtiol, Pierre ;
Nicholson, Andrew G. ;
Tsao, Ming-Sound ;
Tazelaar, Henry D. ;
Churg, Andrew ;
Dacic, Sanja ;
Roggli, Victor ;
Pissaloux, Daniel ;
Maussion, Charles ;
Moarii, Matahi ;
Beasley, Mary Beth ;
Begueret, Hugues ;
Chapel, David B. ;
Copin, Marie Christine ;
Gibbs, Allen R. ;
Klebe, Sonja ;
Lantuejoul, Sylvie ;
Nabeshima, Kazuki ;
Vignaud, Jean-Michel ;
Attanoos, Richard ;
Brcic, Luka ;
Capron, Frederique ;
Chirieac, Lucian R. ;
Damiola, Francesca ;
Sequeiros, Ruth ;
Cazes, Aurelie ;
Damotte, Diane ;
Foulet, Armelle ;
Giusiano-Courcambeck, Sophie ;
Hiroshima, Kenzo ;
Hofman, Veronique ;
Husain, Aliya N. ;
Kerr, Keith ;
Marchevsky, Alberto ;
Paindavoine, Severine ;
Picquenot, Jean Michel ;
Rouquette, Isabelle ;
Sagan, Christine ;
Sauter, Jennifer ;
Thivolet, Francoise ;
Brevet, Marie ;
Rouvier, Philippe ;
Travis, William D. ;
Planchard, Gaetane ;
Weynand, Birgit ;
Clozel, Thomas ;
Wainrib, Gilles .
JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (06) :1037-1053
[45]   Pathologic Grading of Malignant Pleural Mesothelioma: An Evidence-Based Proposal [J].
Pelosi, Giuseppe ;
Papotti, Mauro ;
Righi, Luisella ;
Rossi, Giulio ;
Ferrero, Stefano ;
Bosari, Silvano ;
Calabrese, Fiorella ;
Kern, Izidor ;
Maisonneuve, Patrick ;
Sonzogni, Angelica ;
Albini, Adriana ;
Harari, Sergio ;
Barbieri, Fausto ;
Capelletto, Enrica ;
Catino, Anna Maria ;
Cavone, Domenica ;
De Palma, Angela ;
Fusco, Nicola ;
Lunardi, Francesca ;
Maiorano, Eugenio ;
Marzullo, Andrea ;
Novello, Silvia ;
Papanikolaou, Nikolaos ;
Pasello, Giulia ;
Pennella, Antonio ;
Pezzuto, Federica ;
Punzi, Alessandra ;
Prisciandaro, Elena ;
Rea, Federico ;
Rosso, Lorenzo ;
Scattone, Anna ;
Serio, Gabriella .
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (11) :1750-1761
[46]   Pediatric Mesothelioma With ALK Fusions A Molecular and Pathologic Study of 5 Cases [J].
Argani, Pedram ;
Lian, Derrick W. Q. ;
Agaimy, Abbas ;
Metzler, Markus ;
Wobker, Sara E. ;
Matoso, Andres ;
Epstein, Jonathan I. ;
Sung, Yun-Shao ;
Zhang, Lei ;
Antonescu, Cristina R. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2021, 45 (05) :653-661
[47]   Pathologic diagnosis of malignant mesothelioma: chronological prospect and advent of recommendations and guidelines [J].
Ascoli, Valeria .
ANNALI DELL ISTITUTO SUPERIORE DI SANITA, 2015, 51 (01) :52-59
[48]   Design considerations for early-phase clinical trials of immune-oncology agents [J].
Wages, Nolan A. ;
Chiuzan, Cody ;
Panageas, Katherine S. .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
[49]   Surgery and mesothelioma: If not randomization, at least standardization and registration! [J].
Pass, Harvey .
LUNG CANCER, 2011, 71 (01) :1-2
[50]   Analysis of new treatments proposed for malignant pleural mesothelioma raises concerns about the conduction of clinical trials in oncology [J].
Meirson, Tomer ;
Nardone, Valerio ;
Pentimalli, Francesca ;
Markel, Gal ;
Bomze, David ;
D'Apolito, Maria ;
Correale, Pierpaolo ;
Giordano, Antonio ;
Pirtoli, Luigi ;
Porta, Camillo ;
Gray, Steven G. ;
Mutti, Luciano .
JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)